-
Product Insights
Net Present Value Model: Eplontersen Sodium
Overview Evaluating the value of drugs is a complicated practice and requires a deep knowledge of the drug itself, the market currently and in the future, knowledge of cash inflows and outflows and the potential success rates for each stage of drug development. GlobalData has done all of this work for you, leveraging its gold standard Drugs Intelligence database to create high-value NPV models for purchase on a drug-by-drug basis. Drug Operating Profit Model Eplontersen Sodium Drug Details AKCEA-TTR-LRx is...
-
Product Insights
Net Present Value Model: Olezarsen Sodium
Overview Evaluating the value of drugs is a complicated practice and requires a deep knowledge of the drug itself, the market currently and in the future, knowledge of cash inflows and outflows and the potential success rates for each stage of drug development. GlobalData has done all of this work for you, leveraging its gold standard Drugs Intelligence database to create high-value NPV models for purchase on a drug-by-drug basis. Drug Operating Profit Model Olezarsen Sodium Drug Details AKCEA-APOCIIILRx is...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – eplontersen sodium
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry eplontersen sodium Drug Details AKCEA-TTR-LRx is under development for the treatment of familial amyloid...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – olezarsen sodium
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry olezarsen sodium Drug Details AKCEA-APOCIIILRx is under development for the treatment of severe high...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – volanesorsen sodium
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry volanesorsen sodium Drug Details Volanesorsen sodium (Waylivra) is an antisense oligonucleotide. it is formulated...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – inotersen sodium
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry inotersen sodium Drug Details Inotersen sodium (Tegsedi) is a methoxyethyl phosphorothioate antisense oligonucleotide. It...
-
Product Insights
Transthyretin (ATTR or Prealbumin or TBPA or TTR) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Transthyretin is a transport protein that transports thyroid hormones and retinol (vitamin A). The Transthyretin pipeline drugs market research report outlays comprehensive information on the Transthyretin (ATTR or Prealbumin or TBPA or TTR) targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA), and molecule type. The report also reviews key players involved in Transthyretin (ATTR or Prealbumin or TBPA or TTR) targeted therapeutics development with respective active and dormant or discontinued...